NL7102255A - - Google Patents
Info
- Publication number
- NL7102255A NL7102255A NL7102255A NL7102255A NL7102255A NL 7102255 A NL7102255 A NL 7102255A NL 7102255 A NL7102255 A NL 7102255A NL 7102255 A NL7102255 A NL 7102255A NL 7102255 A NL7102255 A NL 7102255A
- Authority
- NL
- Netherlands
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/126—Acids containing more than four carbon atoms
- C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR707006583A FR2077918B1 (enExample) | 1970-02-24 | 1970-02-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7102255A true NL7102255A (enExample) | 1971-08-26 |
Family
ID=9051186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7102255A NL7102255A (enExample) | 1970-02-24 | 1971-02-19 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3814812A (enExample) |
| BE (1) | BE762399A (enExample) |
| DE (1) | DE2105925C3 (enExample) |
| ES (1) | ES388527A1 (enExample) |
| FR (1) | FR2077918B1 (enExample) |
| GB (1) | GB1301973A (enExample) |
| NL (1) | NL7102255A (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4301176A (en) * | 1980-08-18 | 1981-11-17 | Warner-Lambert Company | Method of administering calcium valproate |
| FR2547499A1 (fr) * | 1983-06-15 | 1984-12-21 | Opochimiotherapie Lab | Medicaments contenant du dipropylacetate de calcium |
| IL72381A (en) * | 1983-07-20 | 1988-03-31 | Sanofi Sa | Pharmaceutical composition based on valproic acid |
| US4913906B1 (en) * | 1985-02-28 | 2000-06-06 | Yissum Res Dev Co | Controlled release dosage form of valproic acid |
| US5070710A (en) * | 1989-02-07 | 1991-12-10 | Sara Lee Corporation | Garment blank and method of making it |
| EP2275096A3 (en) | 2005-08-26 | 2011-07-13 | Braincells, Inc. | Neurogenesis via modulation of the muscarinic receptors |
| EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| WO2007047978A2 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
| EP2314289A1 (en) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
| EP2021000A2 (en) | 2006-05-09 | 2009-02-11 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| WO2008030651A1 (en) | 2006-09-08 | 2008-03-13 | Braincells, Inc. | Combinations containing a 4-acylaminopyridine derivative |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| WO2008097861A2 (en) * | 2007-02-02 | 2008-08-14 | Braincells, Inc. | MODULATION OF NEUROGENESIS WITH BIGUANIDES AND GSK3-ß AGENTS |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2266992A (en) * | 1939-03-15 | 1941-12-23 | American Cyanamid Co | Therapeutic composition |
-
1970
- 1970-02-24 FR FR707006583A patent/FR2077918B1/fr not_active Expired
-
1971
- 1971-02-02 BE BE762399A patent/BE762399A/xx unknown
- 1971-02-09 DE DE2105925A patent/DE2105925C3/de not_active Expired
- 1971-02-19 NL NL7102255A patent/NL7102255A/xx unknown
- 1971-02-23 ES ES388527A patent/ES388527A1/es not_active Expired
- 1971-02-23 US US00117950A patent/US3814812A/en not_active Expired - Lifetime
- 1971-04-19 GB GB2241371A patent/GB1301973A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US3814812A (en) | 1974-06-04 |
| GB1301973A (enExample) | 1973-01-04 |
| ES388527A1 (es) | 1974-04-16 |
| BE762399A (fr) | 1971-08-02 |
| DE2105925A1 (enExample) | 1971-09-09 |
| FR2077918B1 (enExample) | 1973-04-06 |
| FR2077918A1 (enExample) | 1971-11-05 |
| DE2105925C3 (de) | 1974-11-21 |
| DE2105925B2 (de) | 1974-04-04 |